151 related articles for article (PubMed ID: 15297725)
21. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
[TBL] [Abstract][Full Text] [Related]
22. Azathioprine for maintaining remission of Crohn's disease.
Pearson DC; May GR; Fick G; Sutherland LR
Cochrane Database Syst Rev; 2000; (2):CD000067. PubMed ID: 10796482
[TBL] [Abstract][Full Text] [Related]
23. Early onset steroid-dependent ulcerative colitis is a predictor of azathioprine response: a longitudinal 12-month follow-up study.
Chebli LA; Felga GG; Chaves LD; Pimentel FF; Guerra DM; Gaburri PD; Zanini A; Chebli JM
Med Sci Monit; 2010 Feb; 16(2):PI1-6. PubMed ID: 20110928
[TBL] [Abstract][Full Text] [Related]
24. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
25. Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
van Gennep S; de Boer NK; D'Haens GR; Löwenberg M
Inflamm Bowel Dis; 2017 Dec; 24(1):67-77. PubMed ID: 29272488
[TBL] [Abstract][Full Text] [Related]
26. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials.
Mertz Nielsen A; Theede K; Gluud LL; Kiszka-Kanowitz M
Scand J Gastroenterol; 2024 Jun; 59(6):669-673. PubMed ID: 38444060
[TBL] [Abstract][Full Text] [Related]
28. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T
J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127
[TBL] [Abstract][Full Text] [Related]
29. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
30. Transdermal nicotine for induction of remission in ulcerative colitis.
McGrath J; McDonald JW; Macdonald JK
Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126
[TBL] [Abstract][Full Text] [Related]
31. Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review.
Luan ZJ; Li Y; Zhao XY; Wang L; Sun YH; Wang SY; Qian JM
J Dig Dis; 2016 Oct; 17(10):652-659. PubMed ID: 27450969
[TBL] [Abstract][Full Text] [Related]
32. Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.
Ma C; Guizzetti L; Panaccione R; Fedorak RN; Pai RK; Parker CE; Nguyen TM; Khanna R; Vande Casteele N; D'Haens G; Sandborn WJ; Feagan BG; Jairath V
Aliment Pharmacol Ther; 2018 Jun; 47(12):1578-1596. PubMed ID: 29696670
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
Ford AC; Achkar JP; Khan KJ; Kane SV; Talley NJ; Marshall JK; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):601-16. PubMed ID: 21407188
[TBL] [Abstract][Full Text] [Related]
34. Tolerability and usefulness of mercaptopurine in azathioprine-intolerant Japanese patients with ulcerative colitis.
Kuriyama M; Kato J; Suzuki H; Akita M; Hiraoka S; Okada H; Yamamoto K
Dig Endosc; 2010 Oct; 22(4):289-96. PubMed ID: 21175481
[TBL] [Abstract][Full Text] [Related]
35. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
Jairath V; Zou G; Parker CE; Macdonald JK; Mosli MH; Khanna R; Shackelton LM; Vandervoort MK; AlAmeel T; Al Beshir M; AlMadi M; Al-Taweel T; Atkinson NS; Biswas S; Chapman TP; Dulai PS; Glaire MA; Hoekman D; Koutsoumpas A; Minas E; Samaan MA; Travis S; D'Haens G; Levesque BG; Sandborn WJ; Feagan BG
J Crohns Colitis; 2016 May; 10(5):607-18. PubMed ID: 26746169
[TBL] [Abstract][Full Text] [Related]
36. Type I interferons for induction of remission in ulcerative colitis.
Seow CH; Benchimol EI; Griffiths AM; Steinhart AH
Cochrane Database Syst Rev; 2008 Jul; (3):CD006790. PubMed ID: 18646167
[TBL] [Abstract][Full Text] [Related]
37. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy and safety of azathioprine in ulcerative colitis.
Sood R; Ansari S; Clark T; Hamlin PJ; Ford AC
J Crohns Colitis; 2015 Feb; 9(2):191-7. PubMed ID: 25518053
[TBL] [Abstract][Full Text] [Related]
39. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.
Ford AC; Khan KJ; Achkar JP; Moayyedi P
Am J Gastroenterol; 2012 Feb; 107(2):167-76; author reply 177. PubMed ID: 22108446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
